Acute Toxicity Studies of Aluminium Compounds: Antidotal Efficacy of Several Chelating Agents
- 1 April 1987
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 60 (4), 280-283
- https://doi.org/10.1111/j.1600-0773.1987.tb01752.x
Abstract
Four aluminium compounds.sbd.nitrate, chloride, sulphate and bromide.sbd.were administered orally and intraperitoneally to rats and mice. The LD50-values (14 days) were determined. The majority of deaths occurring during the first four days. The clinical and physical signs appearing after intoxication include among others lethargy, decreased locomotor activity, piloerection, weight loss and perorbital bleeding. After 14 days no alterations in liver and renal functions were detected in the animals which received intraperitoneally the LD50-values of aluminium nitrate as a single dose. Aluminium concentrations were highest in liver and spleen. No histopathological lesions could be observed. To compare the efficacies of nine chelating agents on the toxicity of aluminium in mice, the therapeutic index and the therapeutic effectiveness of each chelating agent have been calculated. Malic, succinic, oxalic and malonic acids showed the best results with malic and succinic acids being the most effective. Deferoxamine mesylate (DFOA), sodium salicylate, L-cysteine and citric acid were not so effective as antidotes for acute aluminium toxicity. Aurin tricarboxylic acid (ATCA) should not be used due to its high toxicity.This publication has 15 references indexed in Scilit:
- Short‐term toxicity studies of vanadium in ratsJournal of Applied Toxicology, 1985
- Protection of mice against the lethal effects of sodium metavanadate: A quantitative comparison of a number of chelating agentsToxicology Letters, 1985
- Bone Aluminum and Histomorphometric Features of Renal Osteodystrophy*Journal of Clinical Endocrinology & Metabolism, 1982
- Protection of mice against the lethal effects of sodium arsenite?A quantitative comparison of a number of chelating agents*1Toxicology and Applied Pharmacology, 1981
- Comparison of the effectiveness of several chelators after single administration on the toxicity, excretion, and distribution of cadmiumToxicology and Applied Pharmacology, 1981
- Metabolism and toxicity of aluminum in renal failureThe American Journal of Clinical Nutrition, 1980
- FRACTURING DIALYSIS OSTEODYSTROPHY AND DIALYSIS ENCEPHALOPATHYThe Lancet, 1979
- BRAIN-ALUMINIUM CONCENTRATION IN DIALYSIS ENCEPHALOPATHYThe Lancet, 1978
- The Dialysis Encephalopathy SyndromeNew England Journal of Medicine, 1976
- ALUMINIUM TOXICITY IN RATSThe Lancet, 1972